Dr. Edmund Freund MD Joins Viratech's Advisory Board

Photo of author

STOCKTON, CALIFORNIA/November, 27 2012 /Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the addition of Edmund Freund, MD to its Advisory Committee.

Edmund Freund, MD, completed his undergraduate and medical education at the University of Iowa.  He completed a family practice residency at San Joaquin General Hospital in Stockton, which is affiliated with UC Davis, in 1981.    He began a family practice in Lodi with Vinewood Family Practice in 1981.  Dr. Greund has also held administrative roles at Lodi Memorial Hospital.  In 2002 he became Medical Director of Lodi Memorial Hospital Emergency Medicine Department. In 2009 he returned to family practice with Lodi Memorial Community Clinics. 

“With Dr. Freund’s leadership roles, and his clinical experience in Primary Care and Emergency Medicine over the last 30 years, he understands the need for new ways to reduce health care costs and improve quality of care,” states Dr. Kevin Buckman, the CEO of Viratech.  Dr. Buckman adds, “He will be a great asset to the Advisory Board of Viratech as we implement the use of our social network platforms, research, and other resources that are needed in ER and primary care health.   He also understands the importance of early disease detection,”   He adds, “Working in ER and Primary Care is the best way to see a broad range of medical problems, and we look forward to Dr. Freund’s administrative and practical experience to our Board.”

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.


Contact: Kevin Buckman MD

Viratech, Corp.


Email Contact: info@viratech.org